News | November 24, 2025
Aptus Pharma enters into urology therapy segment
The company will soon be launching a new portfolio of products in this segment
The company will soon be launching a new portfolio of products in this segment
AINU is set to accelerate its expansion footprint, enhance operational capabilities
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
UroKul, Pune is the largest centre to conduct reconstructive urology surgery outside USA and UK
The collaboration between CORONA and Ferring will cater to patients across India
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
The NeuroSakhi initiative aims to close these gaps by strengthening awareness, building patient support networks and improving engagement between healthcare professionals, patients and caregivers across Punjab
The new facilities are designed to provide focused, patient-centric care through advanced diagnostics, minimally invasive treatments, and multidisciplinary expertise
Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration
Subscribe To Our Newsletter & Stay Updated
